Indicated for: hyperkalemia
Route of administration: oral / rectal
Substance: calcium polystyrene sulfonate (potassium binder)
ATC: V03AE01 (Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia)
Calcium polystyrene sulfonate is used for the treatment of hyperkalemia, a condition characterized by high potassium levels in the blood. This medication works by binding potassium in the intestine and removing it from the body through stool.
It is often used in patients with kidney failure or other conditions that impair the body's ability to eliminate potassium. The medication is available as a powder administered orally or rectally, depending on the severity of hyperkalemia.
Treatment must be carried out under strict medical supervision, as excessive use may lead to electrolyte imbalances, such as hypocalcemia or hypermagnesemia. It is important to monitor potassium levels and other electrolytes during treatment.
Side effects may include nausea, constipation, abdominal discomfort, or, in rare cases, intestinal obstruction. Patients should inform their doctor of any adverse reactions.